Hormonal and bacterial regulation of innate lymphoid cells phenotypic changes in multiple sclerosis patients and healthy donors

Main Article Content

Irina V. Nekrasova
Natal’ya S. Glebezdina
Irina L. Maslennikova
Irina Yu. Danchenko
Sergey V. Shirshev

Abstract

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease in which the immune system attacks myelin basic protein of nerve axons. Recently, there has been growing interest in studying the role of a newly described population of innate immunity cells – innate lymphoid cells (ILCs) in the pathogenesis of the disease. At the same time, it was found that during pregnancy there is a weakening of Th1-mediated autoimmune pathologies manifestations, including MS. In this work, we studied phenotypic characteristics of ILC cells in MS patients in comparison with healthy donors after 48 h incubation with pregnancy hormone estriol (E3) and commensal microflora cells. To activate ILC, strains of Ecsherichia coli K12 and Lactobacillus plantarum 8R-A3 were used. ILC phenotype was assessed by flow cytometry using monoclonal antibody staining. It has been established that E3 and bacterial factors are able to regulate the maturation of ILC subtypes in different ways. In particular, MS patients’ cells are more susceptible to hormonal modulation, while those of healthy donors are more susceptible to bacterial modulation. In general, the studied factors influence the phenotypic changes in ILC cells, leading to the transition from one type to another, both in healthy donors and in MS.

Article Details

How to Cite
Nekrasova И. В. ., Glebezdina Н. С. ., Maslennikova И. Л. ., Danchenko И. Ю. ., & Shirshev С. В. . (2023). Hormonal and bacterial regulation of innate lymphoid cells phenotypic changes in multiple sclerosis patients and healthy donors. Bulletin of Perm University. Biology, (1), 76–82. https://doi.org/10.17072/1994-9952-2023-1-76-82
Section
Иммунология
Author Biographies

Irina V. Nekrasova, Perm Federal Research Center UB RAS, Perm, Russia

Candidate of biology, researcher of laboratory of immunoregulation

Natal’ya S. Glebezdina, Perm Federal Research Center UB RAS, Perm, Russia

Сandidate of biology, junior researcher of laboratory of immunoregulation

Irina L. Maslennikova , Perm Federal Research Center UB RAS, Perm, Russia

Сandidate of biology, senior researcher of laboratory of immunoregulation

Irina Yu. Danchenko , E.A. Vagner Perm State Medical University, Perm, Russia

Сandidate of medicine, doctor of medicine, assistant of the department of neurology and medical genetics

Sergey V. Shirshev, Perm Federal Research Center UB RAS, Perm, Russia

Doctor of medicine, professor, head of laboratory of immunoregulation

References

Некрасова И.В., Ширшев С.В. Женские половые стероидные гормоны в регуляции ферментативной активности нейтрофилов // Доклады Академии наук. 2013. Т. 453, № 6. С. 690–693.

Ширшев С.В., Некрасова И.В. Комплексное исследование иммуномодулирующей активности эстриола // Иммунология. 2011. Т. 32, № 2. С. 72–74.

Ширшев С.В. и др. Участие микроРНК в гормональных механизмах регуляции функций NK-клеток // Доклады Академии наук. 2017. Т. 474, № 1. С. 123–127.

Ширшев С.В. и др. Гормональная регуляция дифференцировки дендритных клеток тимуса // Бюллетень экспериментальной биологии и медицины. 2018. Т. 165, № 2. С. 193–197.

Bal S.M., Golebski K., Spits H. Plasticity of innate lymphoid cell subsets // Nature Reviews Immunology. 2020. Vol. 20, № 9. P. 552–565.

Cephus J.Y. et al. Estrogen receptor-α signaling increases allergen-induced IL-33 release and airway inflammation // Allergy. 2021 Vol. 76, № 1. P. 255–268.

Dolati S. et al. Multiple sclerosis: Therapeutic applications of advancing drug delivery systems // Biomedicine and Pharmacotherapy. 2017. Vol. 86. P. 343–353.

Ebbo M. et al. Innate lymphoid cells: major players in inflammatory diseases // Nature Reviews Immunology. 2017. Vol. 17, № 11. P. 665–678.

Elemam N.M., Hannawi S., Maghazachi A.A. Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules // Toxins. 2017. Vol. 9, № 12. P. 398.

Gharibi T. et al. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis // Cellular Immunology. 2015. Vol. 293, № 2. P. 113–121.

Grigg J.B. et al. Antigen-Presenting Innate Lymphoid Cells Orchestrate Neuroinflammation // Nature. 2021. Vol. 600, № 7890. P. 707–712.

Gury‐BenAri M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome // Cell. 2016. Vol. 166, № 5. P. 1231–1246. e13.

Harbo H.F., Gold R., Tintore M. Sex and gender issues in multiple sclerosis // Archive of Therapeutic Advances in Neurological Disorders. 2013. Vol. 6, № 4. P. 237–248.

Hepworth M.R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells // Science. 2015. Vol. 348, № 6238. P. 1031–1035.

Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis // Scandinavian Journal of Immunology. 2011. Vol. 74, № 1. P. 1–13.

Kase N.G., Reyniak J.V. Endocrinology of pregnancy // Mount Sinai Journal of Medicine 1985. Vol. 52, № 1. P. 11–34.

McDonald W.I. et al. Recommended diagnostic criateria for multiple sclerosis: guidelines for the International Panel on diagnosis of multiple sclerosis // Annals of Neurology. 2001. Vol. 50, № 1. P. 121–127.

Moro K., Koyasu S. Innate lymphoid cells, possible interaction with microbiota // Seminars in Immunopathology. 2015. Vol. 37, № 1. P. 27–37.

Nekrasova I., Shirshev S. Estriol in regulation of cell-mediated immune reactions in multiple sclerosis // Journal of Neuroimmunology. 2020. Vol. 349(7). P. 577421.

Neill D.R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity // Nature. 2010. Vol. 464, № 7293. P. 1367–1370.

Neuteboom R.F. et al. Pregnancy in multiple sclerosis: clinical and self-report scales // Journal of Neurology. 2012. Vol. 259. P. 311–317.

Papenfuss T.L. et al. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity // Journal of Immunology. 2011. Vol. 186, № 6. P. 3346–3355.

Pelfrey C.M. et al. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis // Journal of Neuroimmunology. 2005. Vol. 167, № 1–2. P. 190–203.

Russi A.E. et al. Male-Specific IL-33 Expression Regulates Sex-Dimorphic EAE Susceptibility // Proceedings of the National Academy of Sciences of the United States of America. 2018. Vol. 115, № 7. P. E1520–E1529.

Satoh-Takayama N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense // Immunity. 2008. Vol. 29, № 6. P. 958–970.

Sicotte N.L. et al. Treatment of multiple sclerosis with the pregnancy hormone estriol // Annals of Neurology. 2002. Vol. 52, № 4. P. 421–428.

Soldan S.S. et al. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol // Journal of Immunology. 2003. Vol. 171. P. 6267–6274.

Spits H. et al. Innate lymphoid cells–a proposal for uniform nomenclature // Nature Reviews Immunology. 2013. Vol. 13, № 2. P. 145–149.

Voskuhl R.R. et al. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial // Lancet Neurology. 2016. Vol. 15, № 1. P. 35–46.